US Cannabis Market 2022-2027

    Multi User License - $2,500

    In Stock

    Coming Soon

    US CANNABIS MARKET

     

    INTRODUCTION

    Cannabis consists of a collection of three psychotropic seedlings: Cannabis sativa, Cannabis indica, as well as Catharanthus roseus. These leaves and flowers, seeds, as well as other elements of the marijuana plants are used for both pleasurable and therapeutic reasons.

     

    It can be joyful and may reduce the negative effects of a variety of diseases, including chronic pain. Whenever the blossoms of these species are picked and dried, one of the world ’s most serious medications is produced.

     

    Some people call it weeds, another name it pots, but many others term it marijuana. As marijuana grows legalized in more places, new entries for it emerge. People are increasingly using the phrase cannabis to reference to marijuana. Cannabis is commonly used for its sedative properties.

     

    This is used to treat a variety of physical disorders in the United States, particularly severe pain, blindness, and low appetites. Cannabis comprises made up of about 120 elements called cannabinoids.

     

    infographic: US Cannabis Market, US Cannabis Market Size, US Cannabis Market Trends, US Cannabis Market Forecast, US Cannabis Market Risks, US Cannabis Market Report, US Cannabis Market Share

     

    Researchers are also still unsure what every cannabinoid accomplishes, but they also have a decent knowledge of two of cannabinoids, cannabidiol (CBD) and tetrahydrocannabinol (THC). This same FDA really hasn’t licenced the cannabis for just about any medicinal purpose in the United States.

     

    Nonetheless, this same FDA has authorised a number of medications containing specific cannabinoids. The FDA has ruled that THC and CBD-containing substances can indeed be lawfully sold as nutritional supplements.

     

    US CANNABIS MARKET DYNAMICS

    Cannabis legalisation is frequently seen with mixed feelings, as it has been shown to be received with mistrust due to the possibility of abuse. Cannabis legalisation has allowed individuals to practise safe drug use while also discovering its medical advantages.

     

    As little more than a consequence, numerous governments throughout the world are increasingly legalising cannabis use. It is experiencing substantial development as a result of the rising legalisation of cannabis in many locations.

     

    This industry’s expansion can also be linked to rising consumer knowledge of cannabis’s health advantages and expanding medicinal applications. Because of increased legalisation for both medicinal and recreational uses throughout United States, the North American area will lead the industry cannabis industry.

     

    Another of the key problems impeding business expansion is the convoluted regulatory environment for cannabis use. Companies selling marijuana and cannabinoid goods in the United States must follow certain regulatory standards.

     

    As most nations in United States, Europe, as well as Latin America legalize marijuana, there seems to be a big possibility for cannabis to be legalised in the Oceania Region. China, which is already a big manufacturer of industrial hemp, is anticipated becoming a significant concern for the industry cannabis inside the near future. As a result, the legalisation of psychoactive uses has the opportunity to generate a sizable industry.

     

    US CANNABIS MARKET SEGMENTATION

    The US Cannabis Market can be segmented into following categories for further analysis.

    By Application

    • Commercial Application
    • Industrial Application
    • High-Capacity User Application
    • Residential Application

     

    By Usage Classification Type

    • Pain Management
    • Medical Management
    • Neurological Health Management
    • Mental Health Management

     

    By Operational Technology Type

    • Flowers
    • Concentrates
    • Hybrids

     

    By Regional Classification

    • Western Region – USA
    • Mid-West Region – USA
    • Northeast Region – USA
    • Southern Region – USA

     

    RECENT TECHNOLOGICAL TRENDS IN US CANNABIS MARKET

    It is the most widely farmed, transported, and also used substance in the world; as the campaign for legalization develops at home and internationally, marijuana is attracting substantial interest from investors, producers, and academics. Medicinal marijuana makes up a sizable portion of the cannabis business. Consumption in cannabis-legalized states in the United States are primarily above the age of 50.

     

    This demographic information is predicted to promote marijuana consumption in the country due to the increased likelihood of chronic conditions after the age of 50 and the effectiveness of cannabis on such disorders. However, 30 states in the United States have allowed the use of cannabis for medicinal purposes.

     

    The broad interest in cannabis as well as its medical benefits Furthermore, the Food and Drug Administration has authorized several of its derivative chemicals for therapeutic use. Marinol, Syndros, Cesamet, and Epidolex are FDA-approved marijuana medications.

     

    Additionally, throughout the United States, 10 states have authorized recreational cannabis use, while 33 states and the Federal government of Columbia have approved medicinal cannabis usage. California, Washington, but also Colorado are the top three cannabis-selling states.

     

    Cannabis manufacturing in North America has expanded quickly in recent years due to the development of the leading companies’ production facilities.

     

    COMPETITIVE LANDSCAPE

    Most of the other major difficulties related with solid waste mishandling include deteriorating public quality and wellness, poisoning of water bodies, including pollutants in the air.

     

    Increasing urbanization, combined with a constant growth in the worldwide population, has accelerated the deployment of current cannabis procedures for abandoned items while retaining the treatments methods’ social, technical, and economic viability.

     

    Continued attempts toward resource conservation, as well as increasing costs for effective solid cannabis methods across metropolitan agglomerations, will drive market expansion.

     

    Organigram Holdings has been improvising its products under the machined products to have better customer development and focused approach on the technological integrations focusing the consumer needs. The Organigram’s principal facility is a 14-acre campus in Moncton, New Brunswick, including indoor growing and manufacturing.

     

    This facility does have its own consumables and derivatives production facility, as well as in-house extraction capabilities. Its three-level growing method maximizes facility space footage. This firm is allowed to regulate the important aspects of the developing environment and achieve maximum quality and yield in the plants it generates, and it has segments and sub including loading condition grow chambers.

     

    In addition, the Organigram has created its own unique information systems named OrganiGrow, which is a repository that monitors all growth phases including harvesting season, breed, chamber, weather factors, as well as other aspects.

     

    Green Thumb Industries has been focusing on better and innovative development of the generation and dispensing requirements that can have improvised levels of interface and accessibility to the companies. The Transdermal Lotion provides full-body, non-irritating treatment that moisturises the skin and relieves pain.

     

    Hydrolysed oats, Date Seed Extract, Niacinamide, and other naturally potent nutrients are combined to provide complete and consistent relief. Doctor Solomon’s Drops are infused with coconut oil, which was chosen for its proven benefits of simple dosage and assimilation with in system.

     

    Flavourings are used to balance out the cannabinoid and terpene taste profiles and give a variety of supplementary benefits. In addition, the Transdermal Balm provides focused, focused, and low-impairing treatment that moisturises the epidermis and aids in the reduction of soreness.

     

    COMPANIES PROFILED

    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in theIndustry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2027
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2027
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2027
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2027
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix

     

    0
      0
      Your Cart
      Your cart is emptyReturn to Shop